The Netherlands Cancer Institute is running a DNA microarray facility where this technology is used in fundamental research projects and studies on patient material. We are using the Unigene 40k human ...

Although alterations in several specific genes have been implicated in breast cancer progression, greater understanding of the molecular basis of the disease may result from the evaluation of global ...

OGM Can Resolve Previously Unresolved Rare Disease CasesOGM Can Serve as a Gold Standard Technique for Characterization of ...

Cytogenetics is rapidly advancing with innovations that merge traditional chromosome analysis with automation, AI, and high-throughput genomic tools. These developments are improving speed, accuracy, ...

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a ...

The DNA microarray market is witnessing steady growth due to the rising demand for advanced genomic research, personalized medicine, and early disease diagnosis. The increasing prevalence of cancer, ...

For the quarter ended March 2026, Illumina (ILMN) reported revenue of $1.09 billion, up 4.8% over the same period last year. EPS came in at $1.15, compared to $0.97 in the year-ago quarter. The ...

The Medical News Today news team reports on emerging science, cutting-edge research, new treatments, and trending topics in health and medicine. All articles are written by our network of editors and ...